Vincent Center For Reproductive Biology/Thier 931, Department of Obstetrics, Gynecology and Reproductive Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Hum Mol Genet. 2012 Oct 15;21(20):4394-405. doi: 10.1093/hmg/dds272. Epub 2012 Jul 12.
Male patients with Peutz-Jeghers syndrome (PJS) have defective spermatogenesis and are at increased risk of developing Sertoli cell tumors. Mutations in the Liver Kinase B1 (LKB1/STK11) gene are associated with the pathogenesis of PJS and have been identified in non-PJS patients with sporadic testicular cancers. The mechanisms controlled by LKB1 signaling in Sertoli cell functions and testicular biology have not been described. We have conditionally deleted the Lkb1 gene (Lkb1(cko)) in somatic testicular cells to define the molecular mechanisms involved in the development of the testicular phenotype observed in PJS patients. Focal vacuolization in some of the seminiferous tubules was observed in 4-week-old mutant testes but germ cell development appeared to be normal. However, similar to PJS patients, we observed progressive germ cell loss and Sertoli cell only tubules in Lkb1(cko) testes from mice older than 10 weeks, accompanied by defects in Sertoli cell polarity and testicular junctional complexes and decreased activation of the MAP/microtubule affinity regulating and focal adhesion kinases. Suppression of AMP kinase and activation of mammalian target of rapamycin (mTOR) signaling were also observed in Lkb1(cko) testes. Loss of Tsc1 or Tsc2 copies the progressive Lkb1(cko) phenotype, suggesting that dysregulated activation of mTOR contributes to the pathogenesis of the Lkb1(cko) testicular phenotype. Pten(cko) mice had a normal testicular phenotype, which could be explained by the comparative lack of mTOR activation detected. These studies describe the importance of LKB1 signaling in testicular biology and the possible molecular mechanisms driving the pathogenesis of the testicular defects observed in PJS patients.
男性患有 Peutz-Jeghers 综合征(PJS)的患者存在精子发生缺陷,并且患 Sertoli 细胞瘤的风险增加。肝脏激酶 B1(LKB1/STK11)基因的突变与 PJS 的发病机制有关,并已在散发的睾丸癌非 PJS 患者中被发现。LKB1 信号控制的 Sertoli 细胞功能和睾丸生物学的机制尚未被描述。我们已经在体睾丸细胞中条件性缺失了 Lkb1 基因(Lkb1(cko)),以确定与 PJS 患者观察到的睾丸表型发展相关的分子机制。在 4 周龄的突变睾丸中观察到一些生精小管的局灶性空泡化,但生殖细胞发育似乎正常。然而,与 PJS 患者相似,我们观察到 Lkb1(cko)睾丸中年龄大于 10 周的小鼠中生殖细胞逐渐丢失和仅 Sertoli 细胞小管,伴随着 Sertoli 细胞极性和睾丸连接复合体的缺陷以及丝裂原激活蛋白/微管亲和力调节和粘着斑激酶的活性降低。在 Lkb1(cko)睾丸中还观察到 AMP 激酶的抑制和哺乳动物雷帕霉素靶蛋白(mTOR)信号的激活。Tsc1 或 Tsc2 的缺失复制了渐进性的 Lkb1(cko)表型,表明 mTOR 的失调激活有助于 Lkb1(cko)睾丸表型的发病机制。Pten(cko)小鼠具有正常的睾丸表型,这可以通过缺乏检测到的 mTOR 激活来解释。这些研究描述了 LKB1 信号在睾丸生物学中的重要性,以及可能驱动 PJS 患者睾丸缺陷发病机制的分子机制。